Biopharma in China : Innovation, Trends and Dealmaking

by Sven Agten, Ben Wu

Chapter 1: The Chinese healthcare and pharmaceutical market: Ignore at your own peril -- Chapter 2: China regulatory and legal reforms: Gateway to innovation and global integration -- Chapter 3: The golden age of the Chinese biopharma: Explosive growth in a thriving ecosystem -- Chapter 4: Innovation in the Chinese biopharma: From me-too to First-in-class -- Chapter 5: The art of the biopharma deal: The China angle -- Chapter 6: End if the first cycle. A drastic rest, future challenges and opportunities.

MoreLess

Year of publication:	2024
Authors:	Agten, Sven ; Wu, Ben
Publisher:	2024.: Singapore : Springer Nature Singapore 2024.: Singapore : Imprint: Palgrave Macmillan
Subject:	biotech \| pharmaceutical industry \| biopharmaceutical research \| sino-european trade \| innovation \| Pharmaindustrie \| Pharmaceutical industry \| China \| Innovation \| Biotechnologie-Industrie \| Biotechnology industry \| Innovationsmanagement \| Innovation management \| Pharmakologie \| Pharmacology \| Biotechnologie \| Biotechnology \| EU-Staaten \| EU countries

Online Resource

Check full text access |

More access options

Check Google Scholar

In libraries world-wide (WorldCat)

In German libraries (KVK)

subito order

I need help

Extent:	1 Online-Ressource (VII, 155 p. 35 illus., 34 illus. in color.)
Series:	Palgrave pivot
Type of publication:	Book / Working Paper
Language:	English
ISBN:	9789819714711 ; 9789819714704 ; 9789819714728 ; 9789819714735
Other identifiers:	10.1007/978-981-97-1471-1 [DOI]
Source:	ECONIS - Online Catalogue of the ZBW

Persistent link: https://www.econbiz.de/10014519028